31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Health & Education / Health
Some 150 students join Vietnam-made Covid-19 vaccine testing
Anh Kiet - Tran Thao 17:44, 2020/12/11
There are total three testing phases - all must comply with regulations to ensure absolute safety.

About 150 students from medical and pharmaceutical universities in Hanoi have volunteered to join in a trial for Vietnam-made vaccine of Covid-1.

Launched by Nanogen Pharmaceutical Biotechnology JSC and the Vietnam Military Medical Academy in early December, the trial has so far received many proposal from volunteers.

 Volunteers register to participate in the clinical vaccine trial program at the Vietnam Military Medical Academy. Photo: Kinhtedothi.vn

Before the testing, volunteers have to fill out the consent form and stay at the academy in at least 72 hours to confirm their qualified health condition.

Director of the Vietnam Military Medical Academy Do Quyet said that the volunteers of the phase 1 will be examined and screened before being injected as requested by the Ministry of Health. There are total three testing phases - all must comply with regulations to ensure absolute safety.

The volunteers will be discharged and instructed to follow up and take notes themselves at home. Every day the medical staff will visit or call them.

The Ministry of Health has been streamlining the administrative process to put Nanocovax vaccine into use at the shortest time. 

“Nanogen can produce two million doses of vaccine per year. During the clinical trials, we will produce the Covid-19 vaccine while upgrading the factory to optimize capacity to some 30 million doses per year," Ho Nhan, the company’s director, said.

"We plan to reach an ideal capacity of 50 million doses per year,” he added. 

"This is the first clinical trials of locally-made Covid-19 vaccine that whose research process has completed and achieved high results in the pre-clinical trial. We are making every effort to be able to produce vaccines as soon as possible," Mr. Nhan added.

Aside from Nanogen Company, three other units are developing Covid-19 vaccine in Vietnam, including Vabiotech, Polyvac and the Institute of Vaccines and Medical Biologicals (IVAC). Among them, IVAC and Vabiotech may conduct human trial in February and March 2021, respectively.

From December 10, those wishing to join Nanocovax anti-Covid-19 candidate vaccine clinical research program can register directly at the Center for Clinical Trial and Bioequivalence of the Vietnam Military Medical Academy (No. 222 Phung Hung street, Ha Dong district in Hanoi) or by phone: 0388.959.096, 0362.359.084 / 0353.212.500. Alternatively, registration can be made via email: nanocovax@nanogenpharma.com or on the website: nanogenpharma.com.

TAG: 150 students Covid-19 vaccination program human trial
Other news
07:19, 2022/19/26
Hanoi addresses students' mental health issues
School is one of the most critical psychosocial environments for adolescents.
19:11, 2022/11/23
Hanoi strengthens periodic and unexpected inspection in school kitchens
Schools in Hanoi are setting up food safety self-monitoring groups, assigning tasks to individual members to oversee the origin and quality of food used by school kitchens to ensure food safety and hygiene.
12:07, 2022/07/10
Hanoi sets targets for higher adult height by 2030
Hanoi's targets are feasible thanks to an adequate nutritional regimen coupled with a better diet and physical exercise.
20:08, 2022/08/06
Weekly Covid-19 update: Hanoi monitors new variants of coronavirus
The Covid-19 pandemic in Hanoi remains under control, with no fatalities reported.
17:21, 2022/21/04
Japan supports Hanoi-based hospitals in training of rehabilitation for elderly
According to the United Nations, Vietnam's population aging is expected to accelerate by 20 years from 2010, and the speed of aging is faster than that of Japan.
09:20, 2022/20/04
Vietnam – Important health partner of the US: HHS
The cooperation includes strengthening laboratory and surveillance systems, preventing zoonotic and vaccine-preventable diseases in the community, supporting workforce development, and outbreak response.